PAM2L
China,TNGlobal Q&A and Interviews,Biotech / MedTech,Features
Shenzhen-based PAM2L Biotechnologies plans new round of funding to expand capabilities
PAM2L Biotechnologies is one of the finalists of Fund At First Pitch at BEYOND Expo 2024.
August 30, 2024
Temasek firm backs Upscale AI’s $200M Series A financing
January 22, 2026
Temasek firm backs Upscale AI’s $200M Series A financing
January 22, 2026




